Acasti Pharma Inc. (ACST)

$0.5851

-0.00 (-0.44%)
Rating:
Recommendation:
Neutral
Symbol ACST
Price $0.5851
Beta 1.378
Volume Avg. 0.07M
Market Cap 26.498M
Shares () -
52 Week Range 0.56-2.13
1y Target Est -
DCF Unlevered ACST DCF ->
DCF Levered ACST LDCF ->
ROE -10.25% Sell
ROA -8.98% Neutral
Operating Margin -
Debt / Equity 19.66% Neutral
P/E -
P/B 0.25 Neutral
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest ACST news


Ms. Janelle D'Alvise
Healthcare
Biotechnology
NASDAQ Capital Market

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.